Image pharmaphorum Editor Views & Analysis ASCO 2019 and the future of oncology The future of oncology is to be showcased at ASCO 2019 when the world’s leading cancer event returns to McCormick Place in Chicago. Views & Analysis ASCO 2019 Preview – in partnership with Kantar ASCO’s 2019 conference is due to begin in just a few days’ time, highlighting the latest cutting edge cancer drugs and technology. Sales & Marketing Sponsored A blueprint for healthcare: Brand strategy and planning When pharmaceutical and biotech companies are working on their brand strategy and conducting brand planning it is vital that they understand what makes their healthcare customers tick. Market Access Sponsored Launch excellence in a disrupted world – challenges & opport... Overview Load more results
Views & Analysis ASCO 2019 and the future of oncology The future of oncology is to be showcased at ASCO 2019 when the world’s leading cancer event returns to McCormick Place in Chicago.
Views & Analysis ASCO 2019 Preview – in partnership with Kantar ASCO’s 2019 conference is due to begin in just a few days’ time, highlighting the latest cutting edge cancer drugs and technology.
Sales & Marketing Sponsored A blueprint for healthcare: Brand strategy and planning When pharmaceutical and biotech companies are working on their brand strategy and conducting brand planning it is vital that they understand what makes their healthcare customers tick.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
